(805) 483 1185

English
Español
01 Fomat_Logo_Website-min
  • Home
  • Join a Trial
    • Join a Trial
    • Healthy Volunteers
    • Participant Stories
  • Sponsors
    • Phase I Capabilities
    • Phase II- IV Capabilities
    • Diversity
  • About Us
    • About Us
    • Our Investigators
    • Careers
    • Diversity
  • Resources
    • Company Updates
    • Blogs & Updates
    • Events and Conferences
  • Contact FOMAT

Home » oncology » Page 2

Posts tagged: oncology

synovial sarcoma

Potential Treatment for Common Soft-tissue Childhood Cancer

November 26, 2018
by Beatriz Morales

Scientists have developed a potential new therapeutic approach for synovial sarcoma, one of the most common soft-tissue cancers in teenagers and young adults. At present the long-term survival rates for synovial sarcoma patients is well below 50 perc ...

Read More
0
Skin Cancers

Study Links Widely-used Drug Azathioprine to Skin Cancers

October 3, 2018
by Beatriz Morales

A drug used to treat inflammatory bowel disease, arthritis, and vasculitis as well as to prevent organ rejection in transplant patients has been identified as an essential contributor to Skin Cancer development, in a research study carried out at the ...

Read More
0
Cancer drug delivery

New Method Reveals How Well Cancer Drugs Hit Their Targets

July 16, 2018
by Beatriz Morales

Scientists have developed a technique that allows them to measure how well cancer drugs reach their targets inside the body. It shows individual cancer cells in a tumor in real time, revealing which cells interact with the drug and which cells the dr ...

Read More
0
Skin cancer prevention

ASCO: AstraZeneca pioneer Lynparza scores with Zytiga combo in prostate cancer

June 6, 2018
by Beatriz Morales

CHICAGO—At last year’s American Society of Clinical Oncology annual meeting, AstraZeneca posted Lynparza data that would eventually make it the first in its class to break into breast cancer. This time around, it’s trying to grab the same crown in ...

Read More
0
Glioblastoma treatment

Nanoparticles Take on Brain Cancer

May 28, 2018
by Beatriz Morales

Glioblastoma multiforme, a type of brain tumor, is one of the most difficult-to-treat cancers. Only a handful of drugs are approved to treat glioblastoma, and the median life expectancy for patients diagnosed with the disease is less than 15 months. ...

Read More
0
CAR-T cell therapy

CAR-T Immunotherapy Eliminates Metastatic Colorectal Cancer in Mice

May 4, 2018
by Beatriz Morales

Immunotherapy has given patients and oncologists new options, which for some patients, has meant cures for diseases that had been untreatable. Colorectal cancer has a high mortality rate in advanced stages of the disease with few effective therapies. ...

Read More
0
3D render of a medical background with microscopic view of abstract virus cell

Merck’s Keytruda shows up its rivals with NICE backing in bladder cancer

March 19, 2018
by Beatriz Morales

Merck just accomplished a feat its rivals haven’t so far. Friday, England’s National Institute for Health and Care Excellence, the company's Keytruda to treat certain bladder cancer patients, making it the first immuno-oncology med to win the cost w ...

Read More
0
Antabuse

Alcohol-abuse Drug Antabuse Kills Cancer Cells

December 18, 2017
by Beatriz Morales

A new study of Alcohol-abuse Drug Antabuse is effective against cancer cells. The study has researched by an international team including researchers from Karolinska Institutet. The study also identifies a potential mechanism of action for ...

Read More
0
Suicide gene therapy

Parasite Treatment Fights Prostate Cancer

November 15, 2017
by Beatriz Morales

Cancer researchers at the University of Bergen (UiB) in Norway have been experimenting with hundreds of known drugs in recent years to see how they influence cancer cells of Prostate Cancer. Their most recent discovery shows that a medic ...

Read More
0
Preclinical Cancer Drugs Discoveries

Cancer Drug Effective for Heart Failure Treatment, Preclinical Study Shows

May 18, 2017
by Beatriz Morales

Preclinical Cancer Drug Discoveries Researchers from the Gladstone Institutes have discovered that newly-developed cancer drugs may also provide a treatment option for heart failure patients. Heart failure is the leading cause of mortality, hospi ...

Read More
  • First
  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next
  • Last

Contact Us

    Upcoming Events

    ASCO

    May 30 - June 3rd, 2025

    Chicago, IL

    Global SCRS

    Sep 29 - Oct 1, 2025

    Orlando, FL

    AAO 2025​

    Oct 18-20, 2025​

    Orlando, FL

    Full Event List
    • Review us on Google
    • Review us on Yelp

    Conditions & Theraputic Areas

    Join a Trial

    Healthy Volunteers

    Sponsors

    Phase I Capabilities

    Phase II & III Capabilities

    Diversity

    About Us

    Careers

    Investigators

    Contact Us

    • Review us on Google
    • Review us on Yelp

    Contact Us

    FOMAT Medical Research INC,
    300 South A Street Suite 201 Oxnard, CA 93030
    (805) 483 1185
    Trials Information: [email protected]
    General Information: [email protected]

    Contact Us

    FOMAT Medical Research INC,
    300 South A Street Suite 201 Oxnard, CA 93030
    (805) 483 1185
    Trials Information: [email protected]
    General Information: [email protected]
    • Review us on Google
    • Review us on Yelp
    Proud Partner of hyperCORE
    Facebook Linkedin Instagram
    Shopping Basket
    We use cookies to ensure the best possible experience on our website. By continuing to use this site, we will assume that you are happy with itAcceptPrivacy policy